Hanyu Pharmaceutical: Liraglutide preparations and a variety of GLP-1 API contracted orders totaling nearly 600 million yuan
2024-05-02 07:55:44
On May 2nd, Hanyu Pharmaceutical said on the interactive platform today that as of today, the company's liraglutide preparations and a variety of GLP-1 API contracted orders totaled nearly 600 million yuan, and some orders have been shipped one after another; The preparation production base has obtained European Union GMP certification and US cGMP certification, and the API production base has passed Australian TGA-GMP certification and US cGMP certification.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
